Mark H Kuniholm1, Edgar Ong2, Boris M Hogema3, Marco Koppelman3, Kathryn Anastos1,4, Marion G Peters5, Eric C Seaberg6, Yue Chen7, Kenrad E Nelson6, Jeffrey M Linnen2. 1. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY. 2. Hologic, Inc., San Diego, CA. 3. Sanquin Research and Diagnostics, Departments of Virology, Blood-borne Infections and the National Screening Laboratory, Amsterdam, The Netherlands. 4. Department of Medicine, Montefiore Medical Center, Bronx, NY. 5. Department of Medicine, University of California, San Francisco, CA. 6. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 7. Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA.
Abstract
UNLABELLED: Exposure to hepatitis E virus (HEV) is common in the United States, but there are few data on prevalence of HEV/human immunodeficiency virus (HIV) coinfection in U.S. POPULATIONS: We tested 2,919 plasma samples collected from HIV-infected (HIV(+)) women and men enrolled in U.S. cohort studies for HEV viremia using a high-throughput nucleic acid testing (NAT) platform. NAT(+) samples were confirmed by real-time polymerase chain reaction. Samples were selected for testing primarily on the basis of biomarkers of liver disease and immune suppression. Prevalence of HEV viremia was 3 of 2,606 and 0 of 313 in tested plasma samples collected from HIV(+) women and men, respectively. All HEV isolates were genotype 3a. Based on follow-up testing of stored samples, 1 woman had chronic HEV infection for >4 years whereas 2 women had acute HEV detectable at only a single study visit. CONCLUSIONS: To our knowledge, this is the first reported case of chronic HEV infection in an HIV(+) U.S. individual. We also confirm that chronic HEV infection can persist despite a CD4(+) count >200 cells/mm(3). Overall, though, these data suggest that HEV infection is rare in the HIV(+) U.S. population.
UNLABELLED: Exposure to hepatitis E virus (HEV) is common in the United States, but there are few data on prevalence of HEV/human immunodeficiency virus (HIV) coinfection in U.S. POPULATIONS: We tested 2,919 plasma samples collected from HIV-infected (HIV(+)) women and men enrolled in U.S. cohort studies for HEV viremia using a high-throughput nucleic acid testing (NAT) platform. NAT(+) samples were confirmed by real-time polymerase chain reaction. Samples were selected for testing primarily on the basis of biomarkers of liver disease and immune suppression. Prevalence of HEV viremia was 3 of 2,606 and 0 of 313 in tested plasma samples collected from HIV(+) women and men, respectively. All HEV isolates were genotype 3a. Based on follow-up testing of stored samples, 1 woman had chronic HEV infection for >4 years whereas 2 women had acute HEV detectable at only a single study visit. CONCLUSIONS: To our knowledge, this is the first reported case of chronic HEV infection in an HIV(+) U.S. individual. We also confirm that chronic HEV infection can persist despite a CD4(+) count >200 cells/mm(3). Overall, though, these data suggest that HEV infection is rare in the HIV(+) U.S. population.
Authors: X J Meng; R H Purcell; P G Halbur; J R Lehman; D M Webb; T S Tsareva; J S Haynes; B J Thacker; S U Emerson Journal: Proc Natl Acad Sci U S A Date: 1997-09-02 Impact factor: 11.205
Authors: Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young Journal: Clin Diagn Lab Immunol Date: 2005-09
Authors: Richard K Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia Correa; Julio Montaner; Mark S Sulkowski; Francesca J Torriani; Doug T Dieterich; David L Thomas; Diethelm Messinger; Mark Nelson Journal: Hepatology Date: 2006-06 Impact factor: 17.425
Authors: J M Péron; C Bureau; H Poirson; J M Mansuy; L Alric; J Selves; E Dupuis; J Izopet; J P Vinel Journal: J Viral Hepat Date: 2007-05 Impact factor: 3.728
Authors: D L Thomas; P O Yarbough; D Vlahov; S A Tsarev; K E Nelson; A J Saah; R H Purcell Journal: J Clin Microbiol Date: 1997-05 Impact factor: 5.948
Authors: Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok Journal: Hepatology Date: 2003-08 Impact factor: 17.425
Authors: Harry R Dalton; William Stableforth; Prem Thurairajah; Simon Hazeldine; Rene Remnarace; Warshow Usama; Liz Farrington; Noor Hamad; Cyril Sieberhagen; Vic Ellis; Jonathan Mitchell; S Hyder Hussaini; Malcolm Banks; Samreen Ijaz; Richard P Bendall Journal: Eur J Gastroenterol Hepatol Date: 2008-08 Impact factor: 2.566
Authors: S B Willemse; D L Bezuur; P Blom; E Kneppers; J Verheij; H L Zaaijer; M D Hazenberg Journal: Bone Marrow Transplant Date: 2016-12-19 Impact factor: 5.483
Authors: Ashish C Shrestha; Robert L P Flower; Clive R Seed; Anthony J Keller; Veronica Hoad; Robert Harley; Robyn Leader; Ben Polkinghorne; Catriona Furlong; Helen M Faddy Journal: Blood Transfus Date: 2016-07-22 Impact factor: 3.443
Authors: Kenneth E Sherman; Shyam Kottilil; Susan D Rouster; Enass A Abdel-Hameed; Ceejay L Boyce; Heidi L Meeds; Norah Terrault; M Tarek Shata Journal: AIDS Res Hum Retroviruses Date: 2021-05-10 Impact factor: 1.723